Total cost comparison of 2 biopsy methods for nonpalpable breast lesions

American Journal of Managed Care

Volumn 7, Issue 5, 2001, Pages 527-538

  Bodai, B I ^a   Boyd, B ^a   Brown, L ^a   Wadley, H ^a   Zannis, V J ^a   Holzman, M ^a  

^a First Consulting Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BREAST BIOPSY; BREAST LESION; CLINICAL TRIAL; COMPARATIVE STUDY; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; HEALTH CARE FACILITY; HOSPITAL BILLING; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; STAFF TRAINING; SURGICAL EQUIPMENT; VACUUM;

BIOPSY; BREAST NEOPLASMS; COST ALLOCATION; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; UNITED STATES;

EID: 0035001580     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Cancer Resource Center
2. Cancer statistics, 1999
3. Cancer mortality rates fall: A turning point for the nations
4. Screening: Assessment of current studies
5. Large-core needle biopsy of nonpalpable breast lesions
6. Needle-localized breast biopsy for mammographic abnormalities: A community hospital experience
7. Mammographically guided fine-needle aspiration cytology of the breast: Reducing the rate of insufficient specimens
8. Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: The Radiologic Diagnostic Oncology Group 5 Study. The RDOG5 Investigators
9. Ultrasound-guided needle biopsy of the breast
10. Mammographically guided fine-needle aspiration biopsy of nonpalpable breast lesions. Can it replace open biopsy?
11. Quality of Care Information, Coverage Policies, Medicare Coverage Process, Review Issues, Breast Biopsy (#CAG-00040) Decision Memorandum
12. Stereotactic excisional breast biopsies utilizing the advanced breast biopsy instrumentation system
13. Managed Care Clinical Corner: A case for large-core biopsy procedures in the diagnosis of breast cancer
14. Stereotactic breast biopsy of clustered microcalcifications with a directional, vacuum-assisted device
15. Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: Improved reliability with 14-gauge, directional, vacuum-assisted biopsy
16. The evolving practice pattern of the breast surgeon with disappearance of open biopsy for nonpalpable lesions
17. Stereotactic breast biopsy of atypical ductal hyperplasia and ductal carcinoma in situ lesions: Improved accuracy with directional, vacuum-assisted biopsy
18. Stereotactic core needle biopsy of nonpalpable breast lesions: Initial experience with a promising technique
19. Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy
20. US-guided core breast biopsy: Use and cost effectiveness
21. Needle core biopsy guided with mammography: A study of cost effectiveness
22. Stereotactic breast biopsy as an alternative to open excisional biopsy
23. Impact of stereotaxic core breast biopsy on cost of diagnosis
24. Core-needle and surgical breast biopsy: Comparison of three methods of assessing cost
25. A comparison of Medicare reimbursement and results for various imaging-guided breast biopsy techniques
26. Cost effectiveness of stereotactic core needle biopsy: Analysis by means of mammographic findings
27. The role of perspective in defining economic measures for the evaluation of medical technology
28. Evaluation of common breast problems: Guidance for primary care providers
29. Nurse week/health week earnings survey, operating room nurses salaries, national
30. Median pay rates by workplace
31. Analysis of cancers not diagnosed at stereotactic core breast biopsy
32. Stereotactic large-core needle biopsy of 450 nonpalpable lesions with surgical correlation in lesions with cancer or atypical hyperplasia